Form 8-K - Current report:
SEC Accession No. 0001564590-21-015147
Filing Date
2021-03-24
Accepted
2021-03-24 17:15:39
Documents
12
Period of Report
2021-03-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arwr-8k_20210318.htm   iXBRL 8-K 69629
  Complete submission text file 0001564590-21-015147.txt   201905

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arwr-20210318.xsd EX-101.SCH 5812
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20210318_lab.xml EX-101.LAB 19480
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20210318_pre.xml EX-101.PRE 11659
5 EXTRACTED XBRL INSTANCE DOCUMENT arwr-8k_20210318_htm.xml XML 3565
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 21769110
SIC: 2834 Pharmaceutical Preparations